Advertisement

Topics

PubMed Journals Articles About "Medical News Today Test Gives Accurate Prognosis Breast" RSS

09:29 EST 15th December 2018 | BioPortfolio

Medical News Today Test Gives Accurate Prognosis Breast PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Medical News Today Test Gives Accurate Prognosis Breast articles that have been published worldwide.

More Information about "Medical News Today Test Gives Accurate Prognosis Breast" on BioPortfolio

We have published hundreds of Medical News Today Test Gives Accurate Prognosis Breast news stories on BioPortfolio along with dozens of Medical News Today Test Gives Accurate Prognosis Breast Clinical Trials and PubMed Articles about Medical News Today Test Gives Accurate Prognosis Breast for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Medical News Today Test Gives Accurate Prognosis Breast Companies in our database. You can also find out about relevant Medical News Today Test Gives Accurate Prognosis Breast Drugs and Medications on this site too.

Showing "Medical News Today Test gives accurate prognosis breast" PubMed Articles 1–25 of 26,000+

Prognostic impact of multifocal and multicentric breast cancer versus unifocal breast cancer.

The clinical behavior of multifocal and multicentric breast cancers (MMBCs) is not well characterized. We conducted this study to ascertain whether patients with MMBCs have a worse prognosis than patients with unifocal breast cancers (UBC).


Causal interpretation of correlational studies - Analysis of medical news on the website of the official journal for German physicians.

Media frequently draws inappropriate causal statements from observational studies. We analyzed the reporting of study results in the Medical News section of the German medical journal Deutsches Ärzteblatt (DÄ).

Improvement and Application of Radiated Emission Test Method for Medical Microwave Equipment.

Distortion will occur when testing medical microwave products, due to its high power, high frequency, in the existing radiated emission testing process which will cause saturation non-linear of the pre-amplifier. It will lead to test distorted, the test results are not accurate. This article will improve the original test method by adding some suppressing-frequency devices to suppress the main frequency energy and avoid pre-amplifier saturation, eliminate distortion. All of this will ensure the test results...


Inference of patient-specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer.

Breast cancer is one of the most deadly forms of cancer in women worldwide. Better prediction of breast cancer prognosis is essential for more personalized treatment. In this study, we aimed to infer patient-specific subpathway activities to reveal a functional signature associated with the prognosis of patients with breast cancer. We integrated pathway structure with gene expression data to construct patient-specific subpathway activity profiles using a greedy search algorithm. A four-subpathway prognostic...

Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.

Metaplastic breast cancer (MpBC) is a rare histological subtype of breast cancer recognized as a unique pathologic entity in 2000. However, the pathogenesis, optimal therapy, and prognosis of MpBC and the potential effect of systemic treatments on different subtypes of MpBC are not well defined.

First French Pilot Quality Assessment of the EndoPredict Test for Early Luminal Breast Carcinoma.

Genomic signatures are needed for the determination of prognosis in patients with early stage, estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancers. EndoPredict test is a RNA-based multigene assay that assesses the risk of 10-year relapse in this context. Quality assessment is a mandatory requirement for a laboratory to address the analytical quality of these molecular analyses. The aim of the study was to demonstrate the robustness of this prognostic test...

Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis.

The identification of molecular biomarkers for classification of breast cancer is needed to better stratify the patients and guide therapeutic decisions. The aim of this study was to investigate the value of MAPRE1 gene encoding microtubule-end binding proteins EB1 as a biomarker in breast cancer and evaluate whether combinatorial expression of MAPRE1 and MTUS1 gene encoding EB1-negative regulator ATIP3 may improve breast cancer diagnosis and prognosis.

CHANGE IN HEALTHCARE UTILIZATION FOLLOWING DOCUMENTARY TV PROGRAM ABOUT YOUNG BREAST CANCER PATIENTS.

Personal decision-making concerning health can be heavily influenced by the way mass media conveys health messages and news. Research has shown that there is a connection between health news publications and changes in healthcare utilization, not always for the better. In March 2014 a program about young breast cancer patients was broadcasted as part of the popular Israeli documentary TV series "Uvda" (fact), which gained a lot of publicity. We examined whether there is a connection between the controversia...

Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer.

Beginning in 2018, biomarkers including estrogen receptor (ER) status were incorporated in the 8th AJCC staging system. ER expression levels were not considered in these changes. We hypothesized that the levels of ER expression could affect the prognosis of breast cancer.

Localized morphea after breast implant for breast cancer: A case report.

Early breast cancer follow-up guidelines for patients who underwent surgery suggest a regular and accurate clinical examination of the breast area, for an early identification of cutaneous or subcutaneous breast cancer relapse. Nonetheless, breast skin lesions arising in patients treated with mastectomy for breast cancer can be caused by several diseases. A series of diagnostic hypotheses should be considered, not only focusing on cutaneous metastasis, but also on dermatologic and systemic diseases.

Comparison and Discussion of National/Military Standards Related to Flow Measurement of Medical Injection Pump.

Medical injection pump is a commonly used clinical equipment with high risk. Accurate detection of flow is an important aspect to ensure its reliable operation. In this paper, we carefully studied and analyzed the flow detection methods of three standards being used in medical injection pump detection in our country. The three standards were compared from the aspects of standard device, flow test point selection, length of test time and accuracy judgment. The advantages and disadvantages of these standards ...

Lazy, not biased: Susceptibility to partisan fake news is better explained by lack of reasoning than by motivated reasoning.

Why do people believe blatantly inaccurate news headlines ("fake news")? Do we use our reasoning abilities to convince ourselves that statements that align with our ideology are true, or does reasoning allow us to effectively differentiate fake from real regardless of political ideology? Here we test these competing accounts in two studies (total N = 3446 Mechanical Turk workers) by using the Cognitive Reflection Test (CRT) as a measure of the propensity to engage in analytical reasoning. We find that C...

The Significance of the Stromal Response in Breast Cancer: An Immunohistochemical Study of Myofibroblasts in Primary and Metastatic Breast Cancer.

Gene expression profiling of breast cancer has demonstrated the importance of stromal response in determining the prognosis of invasive breast cancer. The host response to breast cancer is of increasing interest to pathologists and may be a future focus for novel pharmacological treatments.

Phosphorylated HER3 and FITC-labeled trastuzumab immunohistochemistry in patients with HER2-positive breast cancer treated with adjuvant trastuzumab.

The development of trastuzumab has significantly improved the prognosis of HER2-positive breast cancer. However, disease recurs in some patients with HER2-positive breast cancer. A new strategy for treating HER2-positive breast cancer is necessary. Although several studies have reported that HER3 is a prognostic factor for HER2-positive breast cancers, phosphorylated HER3 (pHER3) has not been well studied. There has been no survival analysis including immunohistochemistry with trastuzumab as the primary ant...

Delivering Bad or Life-Altering News.

Delivering serious, bad, or life-altering news to a patient is one of the most difficult tasks physicians encounter. Broadly defined as information that may alter a patient's view of his or her future, bad news may include information related to a chronic disease (e.g., diabetes mellitus), a life-altering illness (e.g., multiple sclerosis), or an injury leading to significant change (e.g., a season-ending knee injury). Patients prefer to receive such news in person, with the physician's full attention, and ...

Sharing Serious News With Cancer Patients: Strategies That Can Help.

Sharing serious news is a key communication task that occurs frequently throughout the trajectory of caring for a cancer patient. When sharing serious news, it is important to consider many factors, including those related to patient diversity, such as cultural and family background; language barriers; socioeconomic factors; and health literacy. Importantly, the way in which serious news is discussed significantly affects many outcomes and aspects of patient care. Sharing serious news is not an innate skill...

Overexpression of CXXC5 is a strong poor prognostic factor in ER+ breast cancer.

CXXC5 is a newly identified CXXC-type zinc finger family protein, which is encoded by the gene localised to the 5q31.3 chromosomal region. Previous studies revealed that CXXC5 is associated with various malignant tumours. The aim of the present study was to investigate the prognosis prediction of CXXC5 in different breast cancer subtypes via the Gene Expression Omnibus database and bc-GenExMiner. CXXC5 overexpression was observed as associated with a poor prognosis for oestrogen receptor positive (ER+) bre...

Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer.

Quality-of-life (QOL) has been reported to affect the prognosis of many types of cancer, and several studies used various QOL assessment tools to determine the relationship between QOL and cancer prognosis. In this study, QOL-Questionnaire for Cancer Patients Treated with Anti-Cancer Drugs-the Breast (QOL-ACD-B) was modified to be suitable for preoperative chemotherapy (POC) and was named the QOL-ACD-BP.

Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis.

To examine whether obesity/overweight is a risk predictor for breast cancer recurrence and death by menopausal status in a retrospective study.

Association between MRI Features and Standardized Uptake Value of 18F-FDG PET/CT in Triple-Negative Breast Cancer.

Triple-negative breast cancer (TNBC) is a breast cancer subgroup that lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Certain magnetic resonance imaging (MRI) features of TNBC might reflect the poor prognosis of TNBC. Standardized uptake value (SUV) of [18F]fluorodeoxyglucose positron emission tomography/computed tomography is 1 of predictive prognostic factors for breast cancer. The purpose of this study was to correlate MRI f...

Breast cancer in the GCC countries: A focus on BRCA1/2 and non-BRCA1/2 genes.

The GCC is an economic alliance of six Arab countries, including Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates (UAE). The rate of endogamous marriage among the GCC countries is approaching 100%, with very high consanguineous marriage rates. Although breast cancer is on the rise in the GCC countries, there are dearth of studies reporting on the genetic epidemiology of breast cancer. In this study, we investigated the frequency of BRCA1/2 and non-BRCA1/2 mutations in breast cancer patie...

Impact of Locoregional Treatment on Prognosis of de novo Stage IV Breast Cancer: A Retrospective Long-Term Study of Chinese Population.

This study aimed to evaluate the impact of locoregional resection and radiotherapy on the prognosis of Chinese women with stage IV breast cancer.

Overexpression of Rho-Associated Coiled-Coil Containing Protein Kinase 2 Is Correlated with Clinical Progression and Poor Prognosis in Breast Cancer.

BACKGROUND Rho-associated coiled-coil containing protein kinases 2 (ROCK2) is one of the best characterized targets for the small GTPase Rho. It has been reported that ROCK2 is critical for cancer cell migration and invasion. The objective of this study was to investigate the association of ROCK2 expression with clinicopathological features and overall survival of breast cancer patients. MATERIAL AND METHODS The expression of ROCK2 in breast cancer and paired adjacent normal tissues was detected and compare...

Ultrasonographic and Mammographic Findings of Male Breast Disease.

Most male breast diseases are benign, although malignancies can also occur. Gynecomastia, the most common abnormality in the male breast, has characteristic imaging findings differentiating it from cancer. Fewer than 1% of patients with breast cancer are men, but the incidence of male breast cancer is increasing worldwide. Additionally, breast cancer often presents at a more advanced stage in men than in women due to delayed diagnosis. Understanding imaging features of male breast disease is important for a...

Viewing the Eph Receptors with a focus on Breast Cancer Heterogeneity.

Aberrant expression of different family members of the Eph/ephrin system, which comprises the Eph receptors (Ephs) and their ligands (ephrins), has been implicated in various malignancies including breast cancer. The latter presents as a heterogeneous disease with diverse molecular, morphologic and clinical behavior signatures. This review reflects the existing Eph/ephrin literature while focusing on breast cancer heterogeneity. Hormone positive, HER2 positive and triple negative breast cancer (TNBC) cell l...


Advertisement
Quick Search
Advertisement
Advertisement